|
|
POLYDEX PHARMACEUTICALS PROVIDES THIRD QUARTER REPORT WITH CONTINUED IMPROVEMENT IN SALES AND PROFIT |
| |
|
|
|
|
MICROBICIDES FEATURED IN NASDAQ WORLD AIDS DAY CEREMONY |
| |
|
|
|
|
POLYDEX PHARMACEUTICALS AWARDED FROST & SULLIVAN’S
2006 NORTH AMERICA PRODUCT INNOVATION OF THE YEAR AWARD |
| |
|
|
|
|
POLYDEX SPONSORS XVI INTERNATIONAL AIDS CONFERENCE
SUPPORTING GLOBAL ADVOCACY OF MICROBICIDE DEVELOPMENT |
| |
|
|
|
|
POLYDEX SPONSORS XVI INTERNATIONAL AIDS CONFERENCE
SUPPORTING GLOBAL ADVOCACY OF MICROBICIDE DEVELOPMENT |
| |
|
|
|
|
USHERCELL CLINICAL TRIAL UPDATES
PRESENTED AT INTERNATIONAL MICROBICIDE CONFERENCE |
| |
|
|
|
|
POLYDEX PHARMACEUTICALS LIMITED – 2006 FISCAL YEAR END RESULTS |
| |
|
|
|
|
|
POLYDEX RECEIVES EUROPEAN PATENT COVERAGE ON USE OF USHERCELL TO PREVENT AND TREAT PAPILLOMA VIRUS INFECTIONS |
| |
|
|
|
|
|
POLYDEX PHARMACEUTICALS AND CONRAD ANNOUNCE RESULTS OF USHERCELL CONTRACEPTIVE TRIAL AT PARTNERING CONFERENCE IN CALIFORNIA |
| |
|
|
|
|
|
USHERCELL ENTERS INTERNATIONAL PHASE II TRIAL FOR BACTERIAL VAGINOSIS TREATMENT AND PREVENTION
Phase III HIV Prevention trials continuing in Africa and India
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
